US EditionINVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
- An investigation into Pfizer Inc.'s Board of Directors is being conducted by Berger Montague for potential breaches of fiduciary duties regarding the marketing of Depo-Provera.
- The investigation focuses on whether fiduciary duties were breached in the oversight of Depo-Provera's marketing and sales for contraception and endometriosis treatment.
- Reports suggest a possible link between long-term use of Depo-Provera and an increased risk of meningiomas, a type of brain tumor.
- Berger Montague has represented investors since 1970 and advises Pfizer Inc. Shareholders about the investigation.
Insights by Ground AI
Does this summary seem wrong?
47 Articles
47 Articles
All
Left
5
Center
14
Right
6
Rutland Herald+46 Reposted by 46 other sources
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
PHILADELPHIA, June 3, 2025 /PRNewswire/ -- Berger Montague advises shareholders of Pfizer Inc. ("Pfizer" or the "Company") (NYSE: PFE) about an investigation into Pfizer's Board of Directors for potential breaches of fiduciary duties to Pfizer and its shareholders in connection…
Coverage Details
Total News Sources47
Leaning Left5Leaning Right6Center14Last UpdatedBias Distribution56% Center
Bias Distribution
- 56% of the sources are Center
56% Center
L 20%
C 56%
R 24%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
